One of the most frequently mutated genes in CRC is the KRAS oncogene, component of the RAS/RAF/MEK/ERK signaling pathway downstream of EGFR (Epidermal Growth Factor Receptor), which is a significant regulator of cell growth, proliferation, differentiation and apoptosis. This evidence concerns the gene KRAS and colorectal carcinoma.